[In vivo effectiveness of the sulfonamide sulfachlorpyridazine (SCP) and of the combination of sulfachlorpyridazine and trimethoprim (SCP + TMP) against Haemophilus paragallinarum].
D000284:Administration, Oral; D000818:Animals; D002645:Chickens; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006192:Haemophilus Infections / Q000662:veterinary*; D011201:Poultry Diseases / Q000188:drug therapy*; D013410:Sulfachlorpyridazine / Q000008:administration & dosage* / Q000627:therapeutic use; D013424:Sulfanilamides / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage* / Q000627:therapeutic use
D013424:Sulfanilamides; D014295:Trimethoprim; D013410:Sulfachlorpyridazine
Zur in vivo-Wirksamkeit des Sulfonamids Sulfachlorpyridazin (SCP) und der Kombination Sulfachlorpyridazin-Trimethoprim (SCP/TMP) gegen Haemophilus paragallinarum.